The CMV DNA-PCR Qualitative test is a molecular diagnostic procedure used to detect the presence of cytomegalovirus (CMV) genetic material in a patient’s blood or body fluids. Unlike quantitative testing, which measures viral load, the qualitative test simply confirms whether CMV DNA is present or absent. It is primarily ordered to diagnose active CMV infection, especially in immunocompromised individuals, transplant recipients, pregnant women, and newborns, helping clinicians decide on timely treatment and monitoring strategies.
A positive result indicates CMV DNA is present, confirming active infection or reactivation, requiring medical evaluation and possible antiviral therapy.
A negative result means CMV DNA was not detected, suggesting no active infection, though repeat testing may be needed if symptoms or risks persist.
It is recommended for transplant patients, immunocompromised individuals, pregnant women, and newborns suspected of congenital CMV infection.
Yes, it is used to detect CMV DNA in newborns, confirming congenital infection and guiding early treatment.
No, qualitative testing only confirms presence or absence of CMV DNA. Quantitative testing is required to measure viral load and monitor treatment response.
Not always. A negative result means no detectable CMV DNA but repeat testing may be advised if symptoms or risk factors remain.
...
Didn't recieved OTP Yet? Resend OTP